Peng Q, Ma T, Gao M, Wang X, Pan W
Open Heart. 2025; 12(1).
PMID: 39988343
PMC: 11848664.
DOI: 10.1136/openhrt-2024-003034.
Seetge J, Cseke B, Karadi Z, Bosnyak E, Szapary L
J Clin Med. 2024; 13(23).
PMID: 39685767
PMC: 11641953.
DOI: 10.3390/jcm13237309.
Kilickesmez K, Aras D, Degertekin M, Ozer N, Hacibedel B, Helvacioglu K
Clin Cardiol. 2024; 47(12):e70038.
PMID: 39654285
PMC: 11628632.
DOI: 10.1002/clc.70038.
Li M, Chu M, Shen Y, Zhang S, Yin X, Yang S
JACC Asia. 2024; 4(10):764-773.
PMID: 39553909
PMC: 11561497.
DOI: 10.1016/j.jacasi.2024.07.006.
Gaur U, Gadkari C, Pundkar A
Cureus. 2024; 16(9):e68645.
PMID: 39371719
PMC: 11451514.
DOI: 10.7759/cureus.68645.
Risk factors for cognitive dysfunction amongst patients with cardiovascular diseases.
Pal T, Iantovics L, Preg Z, Nemes-Nagy E, Nyulas K, Baba D
Front Public Health. 2024; 12:1385089.
PMID: 39346594
PMC: 11427290.
DOI: 10.3389/fpubh.2024.1385089.
Relationship between systolic blood pressure and renal function on clinical outcomes in patients with atrial fibrillation: a report from the prospective AF-GEN-UK Registry.
Shantsila A, Lip G, Lane D
J Hypertens. 2024; 42(12):2148-2154.
PMID: 39315543
PMC: 11556885.
DOI: 10.1097/HJH.0000000000003856.
Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold.
Luca F, Abrignani M, Oliva F, Canale M, Parrini I, Murrone A
J Clin Med. 2024; 13(16).
PMID: 39200763
PMC: 11354619.
DOI: 10.3390/jcm13164621.
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation.
Chen K, Hsu Y, Chou C, Hsu C, Chang S, Yu W
J Thromb Thrombolysis. 2024; 57(7):1268-1280.
PMID: 39143401
PMC: 11496318.
DOI: 10.1007/s11239-024-03016-8.
To treat or not to treat: a comparative effectiveness analysis of oral anticoagulant outcomes among U.S. nursing home residents with atrial fibrillation.
Chen Q, Baek J, Goldberg R, Tjia J, Lapane K, Alcusky M
BMC Geriatr. 2024; 24(1):619.
PMID: 39030486
PMC: 11264888.
DOI: 10.1186/s12877-024-05186-9.
Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life.
Andel P, Aamodt A, Gleditsch J, Melin E, Rootwelt-Revheim M, Steine K
Cardiology. 2024; 149(6):571-579.
PMID: 39025051
PMC: 11633895.
DOI: 10.1159/000540007.
Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims.
Lip G, Noxon V, Kang A, Luo X, Atreja N, Han S
J Thromb Thrombolysis. 2024; 57(6):1092-1102.
PMID: 38698197
PMC: 11315758.
DOI: 10.1007/s11239-024-02976-1.
The Association between Coagulation and Atrial Fibrillation.
Rafaqat S, Gluscevic S, Patoulias D, Sharif S, Klisic A
Biomedicines. 2024; 12(2).
PMID: 38397876
PMC: 10887311.
DOI: 10.3390/biomedicines12020274.
Involvement of plasminogen activator inhibitor-1 in p300/p53-mediated age-related atrial fibrosis.
Lai Y, He J, Gao X, Peng D, Zhou H, Xu Y
PeerJ. 2023; 11:e16545.
PMID: 38107584
PMC: 10722982.
DOI: 10.7717/peerj.16545.
Stroke in women between 2006 and 2018: Demographic, socioeconomic, and age disparities.
Jacobs M, Ellis Jr C
Womens Health (Lond). 2023; 19:17455057231199061.
PMID: 37735849
PMC: 10515531.
DOI: 10.1177/17455057231199061.
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040.
Camacho E, Lip G
Eur Heart J Qual Care Clin Outcomes. 2023; 10(4):326-333.
PMID: 37697684
PMC: 11187718.
DOI: 10.1093/ehjqcco/qcad055.
Direct Oral Anticoagulants Versus Vitamin K Antagonist (Warfarin) For Stroke Prevention In Frail Patients With Atrial Fibrillation: A Meta-Analysis.
Desai R, Li A, Mondal A, Shenwai P, Merugu B, Guzman F
Proc (Bayl Univ Med Cent). 2023; 36(2):274-275.
PMID: 36876251
PMC: 9980567.
DOI: 10.1080/08998280.2022.2155926.
Stroke in hemodialysis patients and its association with CHADS-VASC and HAS-BLED scores: a retrospective study.
Sab M, Chelala D, Aoun M, Azar R, Abdel Massih T
Clin Kidney J. 2023; 16(3):596-602.
PMID: 36865009
PMC: 9972838.
DOI: 10.1093/ckj/sfac260.
Matrix Metalloproteinases in Cardioembolic Stroke: From Background to Complications.
Wysocka A, Szczygielski J, Kopanska M, Oertel J, Glowniak A
Int J Mol Sci. 2023; 24(4).
PMID: 36835040
PMC: 9959608.
DOI: 10.3390/ijms24043628.
Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke.
Harrison S, Buckley B, Lane D, Fazio-Eynullayeva E, Underhill P, Hill A
Cardiovasc Drugs Ther. 2023; 38(4):731-737.
PMID: 36692658
PMC: 11266273.
DOI: 10.1007/s10557-023-07433-4.